COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,637 Articles (22,913 medRxiv, 8,724 bioRxiv)

Most recent first Previous |  Page 2279: Articles 22781-22790  | Next

Relations between demographic, geographic, and environmental statistics, and the spread of novel coronavirus disease (COVID-19) in Italy
Rovetta, A., Castaldo, L.
10.1101/2020.09.18.20196980 — Posted: 2020-09-18
Physiological Effect of Prone Positioning in Mechanically Ventilated SARS- CoV-2 Infected Patients with Severe ARDS: Preliminary Analysis of an Observational Study
Roy, A., Behera, S., Pande, A., Bhattacharjee, A., Bhattacharyya, A., Baidya, D. K., Anand, R. K., Ray, B. R., Subramaniam, R., Maitra, S.
10.1101/2020.09.16.20195958 — Posted: 2020-09-18
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia
Ariza, B. E., Torres, Y. X., Salgado, D., Cepeda, M., Gomez, C., Castellanos, J. C., Suarez, F., Cuellar, A., Cardozo, C. C., Angel, J., Franco, M. A.
10.1101/2020.09.15.20195313 — Posted: 2020-09-18
SARS-CoV-2 genomes from Oklahoma, USA
Narayanan, S., Ritchey, J. C., Patil, G., Teluguakula, N., More, S., Malayer, J., Saliki, J., Kaul, A., Ramachandran, A.
10.1101/2020.09.15.20195420 — Posted: 2020-09-18
Inexpensive, versatile and open-source methods for SARS-CoV-2 detection
Graham, T. G. W., Dugast-Darzacq, C., Dailey, G. M., Nguyenla, X. H., Van Dis, E., Esbin, M. N., Abidi, A., Stanley, S. A., Darzacq, X., Tjian, R.
10.1101/2020.09.16.20193466 — Posted: 2020-09-18
High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
Kainulainen, M. H., Bergeron, E., Chatterjee, P., Chapman, A. P., Lee, J., Chida, A., Tang, X., Wharton, R. E., Mercer, K. B., Petway, M., Jenks, H. M., Flietstra, T. D., Schuh, A. J., Satheshkumar, P. S., Chaitram, J. M., Owen, S. M., Finn, M. G., Goldstein, J. M., Montgomery, J. M., Spiropoulou, C. F.
10.1101/2020.09.16.20195446 — Posted: 2020-09-18
COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity
Pace, R. M., Williams, J. E., Järvinen, K. M., Belfort, M. B., Pace, C. D., Lackey, K. A., Gogel, A. C., Nguyen-Contant, P., Kanagaiah, P., Fitzgerald, T., Ferri, R., Young, B., Rosen-Carole, C., Diaz, N., Meehan, C., Caffe, B., Sangster, M. Y., Topham, D. J., McGuire, M. A., Seppo, A., McGuire, M. K.
10.1101/2020.09.16.20196071 — Posted: 2020-09-18
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
Natarajan, H., Crowley, A. R., Butler, S. E., Xu, S., Weiner, J. A., Bloch, E. M., Littlefield, K., Wieland-Alter, W., Connor, R. I., Wright, P. F., Benner, S. E., Bonny, T. S., Laeyendecker, O., Sullivan, D. J., Shoham, S., Quinn, T., Larman, H. B., Casadevall, A., Pekosz, A., Redd, A., Tobian, A. A., Ackerman, M. E.
10.1101/2020.09.16.20196154 — Posted: 2020-09-18
A COVID-19 Nursing Home Transmission Study: sequence and metadata from weekly testing in an extensive nursing home outbreak
van den Besselaar, J. H., Sikkema, R. S., Koene, F. M. H. P. A., van Buul, L. W., Oude Munnink, B. B., Frenay, I., te Witt, R., Koopmans, M. P. G., Hertogh, C. M. P. M., Buurman, B. M.
10.1101/2020.09.15.20195396 — Posted: 2020-09-18
KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney
Ichimura, T., Mori, Y., Aschauer, P., Padmanabha Das, K. M., Padera, R. F., Weins, A., Nasr, M. L., Bonventre, J. V.
10.1101/2020.09.16.20190694 — Posted: 2020-09-18 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).